List of SBIR/STTR awards granted to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in September, 2020 for $924,366.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG056246-02A1 | Phase II | 924,366 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in August, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AT009414-01A1 | Phase I | 225,000 | August 1, 2018 | |||||||
A SBIR Phase I contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in September, 2018 for $225,392.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG061986-01 | Phase I | 225,392 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in September, 2022 for $737,376.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG081162-01A1 | Phase II | 737,376 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in January, 2016 for $243,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AT009041-01 | Phase I | 243,994 | January 1, 2016 | |||||||
A STTR Phase I contract was awarded to NEW YORK R&D CENTER FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS, INC. in September, 2017 for $225,042.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AG056246-01A1 | Phase I | 225,042 | September 15, 2017 |
